Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart FailurePrediction of Death at Different Stages of the Disease
Stephanie Neuhold, MD*,
Martin Huelsmann, MD*,*,
Guido Strunk, PhD ,
Brigitte Stoiser, MD ,
Joachim Struck, PhD ,
Nils G. Morgenthaler, MD,
Andreas Bergmann, PhD,
Deddo Moertl, MD*,
Rudolf Berger, MD* and
Richard Pacher, MD*
* Department of Cardiology, Medical University of Vienna, Vienna, Austria
Department of Infectious Diseases, Medical University of Vienna, Vienna, Austria
Research Institute for Health Care Management and Economics, University of Economics and Business Administration, Vienna, Austria
B.R.A.H.M.S. AG, Hennigsdorf, Germany.
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Box Plots of Plasma BNP, Copeptin, and GFR
Median levels of BNP, copeptin, and GFR depending on NYHA functional class. BNP = brain natriuretic peptide; GFR = glomerular filtration rate; NYHA = New York Heart Association.
BNP = brain natriuretic peptide; GFR = glomerular filtration rate; NYHA = New York Heart Association.
|
|
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 ROC for 24-Month Survival
Area under receiver-operator characteristic (ROC) curves for 24-month survival for copeptin, BNP, and copeptin plus BNP. AUC = area under the receiver-operator characteristic curve; other abbreviations as in Figure 1.
|
|
|
